Recent Updates — MEG
On October 7, 2026, Janet Risi Field resigned from the Board of Directors of Onterris, Inc., effective immediately. The company stated that her decision was due to personal reasons and not related to any disagreements regarding operations or policies. Onterris, Inc. operates in the biotechnology sector.
Onterris, Inc. declared a dividend of one preferred share purchase right for each outstanding common share to holders of record on August 17, 2026. The company entered into a Rights Agreement with Computershare Trust Company as rights agent. Each right entitles the holder to purchase one-thousandth of a Series B Preferred Share at $105.00 per unit. The rights will separate from common stock upon the earlier of ten days following a public announcement that an acquirer has obtained 15% or more beneficial ownership, or ten business days after the commencement of such a tender offer. The rights expire on August 4, 2027. Onterris, Inc. operates in the biotechnology industry and develops therapies for rare diseases.
Onterris, Inc. declared a dividend of one preferred share purchase right for each outstanding common share to holders of record on August 17, 2026. The company entered into a Rights Agreement with Computershare Trust Company, N.A., establishing a poison pill defense mechanism. Each right entitles the holder to purchase one-thousandth of a Series B Preferred Share at $105.00 per unit. The rights will separate from common stock and trade independently upon the earlier of ten days following a public announcement that an entity has acquired 15% or more beneficial ownership, or ten business days after the commencement of such a tender offer. If triggered by an 'Acquiring Person,' the rights become exercisable for shares valued at twice the exercise price (flip-in) or allow exchange for acquirer stock in a merger (flip-over). The board may redeem the rights at $0.001 per right prior to any triggering event. Onterris, Inc. operates in the technology sector, providing data analytics and artificial intelligence solutions.
Onterris reported Q2 2026 revenue of $186.7 million and net income of $1.4 million ($0.04 diluted EPS), down from $234.5 million and $18.4 million in the prior year, driven by historically low environmental emergency response activity. The company updated its full-year 2026 revenue guidance to $740–$790 million (from $840–$900 million) and Adjusted EBITDA guidance to $117–$120 million (from $125–$130 million). Onterris announced a Board-led strategic review of its business, portfolio, and capital allocation, including potential acquisition interest. Concurrently, the Board adopted a limited-duration stockholder rights plan effective immediately to protect the integrity of this review process. The company operates in the environmental solutions industry.